ETN vs ORCL: Which Is the Better Buy?

Side-by-side comparison of Eaton Corporation plc and Oracle Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-24.
Eaton Corporation plc Β· Industrials
$438.76
+32.2% upside to fair value
Med Conviction Grade B High Quality
VS
Oracle Corporation Β· Technology
$149.12
+45.0% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
ORCL has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric ETN ORCL
Current Price $438.76 $149.12
Fair Value Estimate $579.99 $216.22
Upside to Fair Value +32.2% +45.0%
Market Cap $170.4B $429.5B
Forward P/E β€” β€”
EV / EBITDA 29.6x 14.6x
Price / Sales 5.7x 6.0x
Price / FCF 37.9x β€”
Revenue Growth YoY +21.4% +29.6%
Gross Margin 35.9% 63.9%
Operating Margin 17.7% 32.4%
Return on Equity 19.6% 42.6%
Dividend Yield 0.99% 1.34%
FCF Yield 2.64% β€”
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
ETN β€” Eaton Corporation plc
Eaton Corporation plc is a Dublin-headquartered power management company with roughly 97,303 employees, operating electrical, aerospace, vehicle and eMobility segments that supply power distribution, circuit protection, power quality and reliability equipment and services. The business quality is high: TTM gross margin of 35.9%, TTM operating margin of 17.7%, TTM net margin of 12.8% and ROE of 19…
ORCL β€” Oracle Corporation
Oracle is a global enterprise software and cloud infrastructure provider whose portfolio spans the Oracle Database, Java, Fusion Cloud SaaS applications (ERP, EPM, SCM, HCM), NetSuite, and Oracle Cloud Infrastructure, sold through a direct sales force to businesses, governments, and educational institutions worldwide. The business quality is high on fundamentals: trailing-twelve-month gross margi…
Accumulation Zones
Metric ETN ORCL
Zone Low $434.99 $162.16
Zone High $492.99 $183.79
In Buy Zone? Yes Yes
← ETN Research    ORCL Research β†’    All Research